IM8 raises $1 billion, and signals where premium consumer health is heading

This week, IM8 (the AI-native wellness brand co-founded by David Beckham and backed by Prenetics) closed $1 billion in growth financing from General Catalyst's Customer Value Fund. The structure is notable: rather than dilutive equity, General Catalyst finances up to 70% of IM8's marketing spend in exchange for a capped share of revenue from the customer cohorts it funds. IM8 delivered $17 million in revenue in June alone, its strongest month on record, and is guiding to more than $400 million for 2027. In our point of view, the financing structure is more interesting than the valuation. It shows that underlying customer economic capabilities (CAC / LTV) are seen as a strategic asset by itself. For non-DTC or omnichannel business models that means that the near-term priority needs to be building infrastructure to proof acquisition and retention economics at cohort-level, a bar most legacy consumer health players can't clear yet.